Why is Kwality Pharma falling/rising?

As of 22-Jul, Kwality Pharmaceuticals Ltd is experiencing a price increase, currently at 1,153.00, reflecting a rise of 8.15 (0.71%). Today's price summary indicates that the stock has outperformed its sector by 1.62% and has shown a trend reversal after two consecutive days of decline. The stock's performance over the past month has been strong, with a 10.55% increase, and it has delivered impressive returns of 131.53% over the past year. However, despite these positive indicators, there are concerns regarding long-term growth, as net sales have decreased at an annual rate of -6.73% over the last five years, and the operating profit has also declined by -27.20%. The company's ability to service debt remains strong, with a low Debt to EBITDA ratio of 1.03 times, and it has reported significant profit growth, which may contribute to the recent price movement.
In the broader market context, the stock's short-term performance has been notably better than the benchmark, with a 1-week return of -3.44% compared to the Sensex's -0.47%. This suggests that while the stock has faced some recent volatility, it has managed to maintain a positive trajectory in the longer term, outperforming the benchmark significantly over the past year and three years. However, the lack of domestic mutual fund investment, which stands at 0%, may indicate a cautious sentiment among institutional investors regarding the stock's valuation and growth prospects. Overall, while the stock shows strong short-term gains and positive financial results, the underlying concerns about long-term growth and investor participation could influence its future performance.